One area that we at CBI are developing an interest in is microimaging-which would include:
- SPECT
- PET
- CT
- Micro CT (in vivo and ex vivo, specimen)
- MRI
- Micro Ultrasound
- Optical
- Intravital Microscopy
- Microdialysis
To this end, we are working to collaborate with Biolaurus, a microimaging group with excellent expertise in this technology. Currently, we are planning for imaging in several models including Parkinson’s, Glomerular nephritis, bleomycin-induced pulmonary fibrosis and xenograft. Also, imaging can be conducted to assess nephrotoxicity of novel therapeutics as a form of safety pharmacology.
If you have an interest in how microimaging can help your preclinical program-we would love to talk to you about it!
